On 31 March 2020, the UK Foreign and Commonwealth Office (“FCO“) announced that the Instrument in Support of Trade Exchanges (INSTEX) had successfully concluded its first transaction.

This transaction involved the successful export of medical goods from Europe to Iran, and paves the way for future transactions. In its announcement, the FCO stated: “Now the first transaction is complete, INSTEX and its Iranian counterpart STFI [(Special Trade and Finance Instrument)] will work on more transactions and enhancing the mechanism.”

INSTEX was established in January 2019 to allow European and Iranian entities to continue trading, in spite of increasing US pressure on Iran. So far, 9 European nations have signed up as shareholders of INSTEX: the UK, France, Germany, Belgium, Denmark, Finland, the Netherlands, Norway and Sweden.

This announcement comes just over a month after the JCPOA Joint Commission noted their support of INSTEX.

Author

Sunwinder (Sunny) Mann is a Partner and is Chair of our International Commercial and Trade Global Practice Group. Our Trade team has been ranked Tier 1 by Legal 500 UK for over 20 years. He is currently based in our London office, but has also worked in our offices in Washington, D.C., New York, Sydney and Hong Kong. Sunny's practice focuses on international trade compliance and, in particular, export controls and trade sanctions, as well as anti-bribery. He has worked on a number of significant compliance and investigations matters. He leads our Firm's Geopolitical Risks Taskforce, having coordinated our Firm's support to clients responding to the ongoing Russia crisis.